COMBINATION OF A 17 -ALPHA -HYDROXYLASE (C17, 20 - LYASE) INHIBITOR AND A SPECIFIC PI-3K INHIBITOR FOR TREATING A TUMOR DISEASE
- Application ID: EP13729566
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Novartis Pharma AG is specialized in A61. Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.